for enquiries or appointments
Serangoon Garden

HPV / Vaccination

What is HPV and HPV Infection?

HPV stands for Human Papillomavirus, is a virus that can infect both males and females and cause potentially serious diseases. There are more than 100 types of HPV strains which can be broadly classified into two categories: High-risk (oncogenic) HPV types and low-risk (non-oncogenic) HPV types.

High-risk (oncogenic) HPV types can cause cancer. The more common high risk HPV types are 16, 18, 31, 33, 45, 52, and 58 which are responsible for the majority of HPV-related cancer such as cervical, anal, vaginal, and vulvar cancers.

Low-risk (non-oncogenic) HPV types do not cause cancer, but they can cause cauliflower-shaped growths like genital warts (condylomata acuminata). HPV Types 6 and 11 are responsible for approximately 90% of all genital warts cases. They usually present as multiple growths - usually 5 to 15, 1-10 mm diameter and usually found in areas of trauma during sex. There may also be co-infection with oncogenic “high-risk” HPV. These high risk cancer causing HPV may give rise to subclinical lesions, intraepithelial neoplasia (IN) and anogenital cancer.

The HPV vaccination is used to protect against the following diseases that can be caused by various types of HPV:

  • Cervical cancer
  • Vulvar and vaginal cancers
  • Anal cancer
  • Precancerous cervical, vulvar, vaginal and anal lesions
  • Genital warts
Who is at risk of HPV infection?

The risk of HPV infection increases with the number of sexual partners: the greater the number of sexual partners, the higher the risk of HPV infection. Having sexual activity with a partner who has had multiple sex partners can also increases the risk. While using condoms can help reduce the risk of HPV infection, condoms however, do not cover all genital skin and does not guarantee 100% protection.

People with weakened immune systems (e.g. may be due to Human Immunodeficiency Virus (HIV) / Acquired Immune Deficiency Syndrome (AIDS) or on immune-system suppressing drugs) are also at higher risk of HPV infection.

Types of HPV vaccines

Our clinic offers the 9-valent HPV vaccine. The 9-valent HPV vaccine is approved for both MEN and WOMEN.

The nine-valent HPV vaccine is indicated for prevention of diseases caused by Human Papillomavirus types 6, 11, 16, 18, 31, 33, 45, 52, and 58.

Immunization with HPV vaccine is recommended to start in boys and girls, men and women from 9 to 26 years of age.

The HPV vaccines work best before you have started having sex or sexual activity. Even if you have started having sex or sexual activity, you can still be protected against the types of human papillomavirus that you have not already been exposed to.

HPV Vaccination Dosing and Schedule

The HPV vaccine is given as an injection. You will receive 3 doses of the vaccines in the following interval:

  • First dose: at a date you and your doctor choose
  • Second dose: 1-2 months after the first dose
  • Third dose: 3-4 months after the second dose

You are strongly recommended to complete all three doses to get the full benefits. If you miss a dose, your doctor or health care provider will advise and decide when you can receive your missed dose.

Who should get vaccinated against HPV?

We recommend HPV vaccination for all males and females at risk of HPV infection, especially before introduction to sexual activity. BUT you can still receive HPV vaccination and be protected against HPV even if you are already sexually active because you may not have been exposed to HPV yet.

Medisave Claim for HPV Vaccination

HPV 9-valent vaccine is not eligible for Medisave Claim.

Cost and Price for HPV Vaccination

The 9-valent HPV vaccine at our clinic costs: 

For NON RESIDENTS - $350 per dose (before GST)

For LOCAL RESIDENTS - $300 per dose or $900 $855 for package of 3 doses (before GST) 

Please call 62884882 or email for more details.

IMPORTANT NOTICE: HPV 4-valent vaccine will be DISCONTINUED in Singapore in July 2022. We will no longer accept NEW patients for the 4-valent HPV vaccine from 1 January 2022. Current patients will not be affected as long as they adhere to the vaccination schedule.